ACCESSION: MSBNK-SMB_Measured-HSA001P0139002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 109
COMMENT: RAW_SPEC {'BLK02_9031': {'bp': 1818160.0, 'sum': 3574359.0}, 'BLK02_8968': {'bp': 1531277.0, 'sum': 3021683.0}, 'ProcedureBlank_9031': {'bp': 1523269.0, 'sum': 2789095.0}, 'BLK02_8905': {'bp': 1283609.0, 'sum': 2526941.0}, 'ProcedureBlank_8968': {'bp': 1118426.0, 'sum': 2131627.0}, 'BLK02_8843': {'bp': 1075604.0, 'sum': 2098681.0}, '1_posi_9054': {'bp': 1040911.0, 'sum': 1887339.0}, 'ProcedureBlank_8906': {'bp': 917524.0, 'sum': 1715266.0}, '1_posi_8991': {'bp': 858115.0, 'sum': 1547570.0}, 'BLK02_8779': {'bp': 795719.0, 'sum': 1607267.0}, '1_posi_8928': {'bp': 744895.0, 'sum': 1354587.0}, '2_posi_9033': {'bp': 709980.0, 'sum': 1255385.0}, 'ProcedureBlank_8843': {'bp': 688357.0, 'sum': 1306217.0}, 'BLK01_9097': {'bp': 617411.0, 'sum': 1160479.0}, '3_posi_9075': {'bp': 607365.0, 'sum': 1068685.0}, '1_posi_8866': {'bp': 605454.0, 'sum': 1119602.0}, 'ProcedureBlank_8781': {'bp': 555123.0, 'sum': 1063652.0}, '2_posi_8970': {'bp': 541920.0, 'sum': 967311.0}, '3_posi_9011': {'bp': 519351.0, 'sum': 920560.0}, 'BLK02_8719': {'bp': 516673.0, 'sum': 1059713.0}, '2_posi_8908': {'bp': 489179.0, 'sum': 871048.0}, 'BLK02_8656': {'bp': 469369.0, 'sum': 979344.0}, '4_posi_9035': {'bp': 457472.0, 'sum': 798846.0}, '1_posi_8803': {'bp': 452939.0, 'sum': 828616.0}, 'BLK01_9035': {'bp': 445289.0, 'sum': 878996.0}, '5_posi_9054': {'bp': 435086.0, 'sum': 733994.0}, '3_posi_8948': {'bp': 428469.0, 'sum': 737599.0}, 'ProcedureBlank_8717': {'bp': 417257.0, 'sum': 817239.0}, '4_posi_8971': {'bp': 414876.0, 'sum': 731435.0}, '2_posi_8847': {'bp': 380431.0, 'sum': 675115.0}, 'BLK02_8591': {'bp': 380070.0, 'sum': 822627.0}, '8_posi_9078': {'bp': 349844.0, 'sum': 601110.0}, 'ProcedureBlank_8655': {'bp': 345971.0, 'sum': 727713.0}, '6_posi_8991': {'bp': 345707.0, 'sum': 571197.0}, '6_posi_9054': {'bp': 344308.0, 'sum': 588976.0}, 'BLK01_8974': {'bp': 340087.0, 'sum': 687354.0}, '5_posi_8991': {'bp': 339714.0, 'sum': 608144.0}, '1_posi_8742': {'bp': 334389.0, 'sum': 663063.0}, '7_posi_9077': {'bp': 333758.0, 'sum': 577388.0}, 'BLK02_8531': {'bp': 325429.0, 'sum': 738146.0}, '7_posi_9015': {'bp': 322880.0, 'sum': 568962.0}, '3_posi_8888': {'bp': 321334.0, 'sum': 554002.0}, '4_posi_8908': {'bp': 311415.0, 'sum': 539679.0}, '3_posi_8826': {'bp': 305035.0, 'sum': 556673.0}, '5_posi_8928': {'bp': 303449.0, 'sum': 520568.0}, '10_posi_9059': {'bp': 301043.0, 'sum': 542793.0}, '2_posi_8785': {'bp': 293978.0, 'sum': 557675.0}, '6_posi_8932': {'bp': 285172.0, 'sum': 495495.0}, '8_posi_9015': {'bp': 283557.0, 'sum': 508401.0}, '9_posi_9037': {'bp': 280336.0, 'sum': 509351.0}, 'BLK02_8471': {'bp': 277167.0, 'sum': 608461.0}, '4_posi_8850': {'bp': 274020.0, 'sum': 497754.0}, '12_posi_9038': {'bp': 272346.0, 'sum': 488964.0}, '7_posi_8951': {'bp': 269570.0, 'sum': 460536.0}, '1_posi_8679': {'bp': 263868.0, 'sum': 523751.0}, 'BLK01_8910': {'bp': 262634.0, 'sum': 515532.0}, 'ProcedureBlank_8591': {'bp': 262230.0, 'sum': 574450.0}, '10_posi_8996': {'bp': 259732.0, 'sum': 477179.0}, '11_posi_9059': {'bp': 253211.0, 'sum': 475562.0}, 'ProcedureBlank_8532': {'bp': 249276.0, 'sum': 529330.0}, '14_posi_9038': {'bp': 246729.0, 'sum': 450793.0}, '9_posi_8974': {'bp': 242479.0, 'sum': 460372.0}, '13_posi_8994': {'bp': 240761.0, 'sum': 417173.0}, '13_posi_9056': {'bp': 239847.0, 'sum': 469232.0}, 'BLK02_8407': {'bp': 233930.0, 'sum': 577350.0}, '15_posi_9016': {'bp': 230911.0, 'sum': 417147.0}, '16_posi_9058': {'bp': 229158.0, 'sum': 414524.0}, '8_posi_8954': {'bp': 228380.0, 'sum': 425766.0}, '2_posi_8724': {'bp': 228124.0, 'sum': 456499.0}, 'BLK02_8340': {'bp': 226258.0, 'sum': 525595.0}, '6_posi_8867': {'bp': 226172.0, 'sum': 429999.0}, '5_posi_8869': {'bp': 225536.0, 'sum': 412856.0}, '11_posi_8996': {'bp': 225468.0, 'sum': 405084.0}, '7_posi_8893': {'bp': 222550.0, 'sum': 395086.0}, '15_posi_9080': {'bp': 219530.0, 'sum': 427968.0}, '14_posi_8975': {'bp': 216351.0, 'sum': 381319.0}, '12_posi_8974': {'bp': 215620.0, 'sum': 408471.0}, '2_posi_8662': {'bp': 212035.0, 'sum': 435511.0}, '1_posi_8619': {'bp': 210222.0, 'sum': 460037.0}, '10_posi_8936': {'bp': 205104.0, 'sum': 398117.0}, 'ProcedureBlank_8468': {'bp': 203838.0, 'sum': 451072.0}, '16_posi_8995': {'bp': 202816.0, 'sum': 395258.0}, '18_posi_9081': {'bp': 201806.0, 'sum': 359412.0}, '17_posi_9077': {'bp': 200507.0, 'sum': 373939.0}, '18_posi_9018': {'bp': 199152.0, 'sum': 364551.0}, '6_posi_8807': {'bp': 198814.0, 'sum': 380588.0}, '17_posi_9015': {'bp': 196138.0, 'sum': 378863.0}, '4_posi_8769': {'bp': 195672.0, 'sum': 381986.0}, 'ProcedureBlank_8406': {'bp': 194662.0, 'sum': 446277.0}, '11_posi_8935': {'bp': 194518.0, 'sum': 350383.0}, '8_posi_8893': {'bp': 192850.0, 'sum': 363297.0}, '12_posi_8911': {'bp': 191634.0, 'sum': 364501.0}, '17_posi_8952': {'bp': 188011.0, 'sum': 354693.0}, '15_posi_8952': {'bp': 186552.0, 'sum': 324931.0}, '9_posi_8912': {'bp': 186528.0, 'sum': 349315.0}, '5_posi_8806': {'bp': 184610.0, 'sum': 337715.0}, '13_posi_8932': {'bp': 181356.0, 'sum': 341385.0}, '8_posi_8829': {'bp': 180620.0, 'sum': 357973.0}, '19_posi_9084': {'bp': 177947.0, 'sum': 343165.0}, '7_posi_8828': {'bp': 176961.0, 'sum': 363009.0}, '3_posi_8748': {'bp': 175459.0, 'sum': 341845.0}, '1_posi_8539': {'bp': 173213.0, 'sum': 398973.0}, 'ProcedureBlank_8343': {'bp': 167646.0, 'sum': 402312.0}, '16_posi_8933': {'bp': 167403.0, 'sum': 314033.0}, '9_posi_8852': {'bp': 166345.0, 'sum': 342788.0}, '18_posi_8956': {'bp': 163240.0, 'sum': 320721.0}, '14_posi_8914': {'bp': 158577.0, 'sum': 302545.0}, '10_posi_8871': {'bp': 155783.0, 'sum': 309470.0}, '15_posi_8890': {'bp': 150701.0, 'sum': 287239.0}}
COMMENT: RETENTION_TIME_STDEV 0.355
COMMENT: PRECURSOR_M/Z_RAW 139.122620
COMMENT: PRECURSOR_M/Z_STDEV 0.000047
COMMENT: PRECURSOR_IN_MS1 ND
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.087; C8H14N2; [M+H]+; delta(ppm) -0.086884
COMMENT: PROPOSED_MF MS-FINDER 3.182; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_MF SIRIUS5_Sirius 15.654; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_MF SIRIUS6_Sirius 32.018; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N2; [M+H]+; delta(ppm) -0.092676
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.026; AIUVAZQMVWSJEN-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.859; RLEMOPKSUBPPLL-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,4,5-trimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.811; FPLOWPOUHNRUMN-UHFFFAOYSA-N; [M+H]+; 2-pentan-3-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FPLOWPOUHNRUMN-UHFFFAOYSA-N; [M+H]+; 2-pentan-3-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.920; AIUVAZQMVWSJEN-UHFFFAOYSA-N; [M+H]+; 3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.895; RLEMOPKSUBPPLL-UHFFFAOYSA-N; [M+H]+; 3-ethyl-1,4,5-trimethyl-1H-pyrazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.463; UPYVYJSWGZMBOU-UHFFFAOYSA-N; [M+H]+; 1-pentylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.311; WHLZPGRDRYCVRQ-UHFFFAOYSA-N; [M+H]+; 1-butyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.036; YZICFVIUVMCCOC-UHFFFAOYSA-N; [M+H]+; 3-piperidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.793; DSMAHJDZYJDGTD-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.563; SVNWKKJQEFIURY-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(2-methylpropyl)imidazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.516; OSDDDHPYSNZBPF-UHFFFAOYSA-N; [M+H]+; 4-pyrrolidin-1-ylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; ZNKPVILXADENLY-UHFFFAOYSA-N; [M+H]+; (1-propylpyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.289; CWTWISUHUSOWMU-UHFFFAOYSA-N; [M+H]+; 3-amino-1-methylcyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.281; FOILTVVMJVTRIH-UHFFFAOYSA-N; [M+H]+; 1-amino-4-methylcyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.280; MIJYJUOXVFSADM-QMMMGPOBSA-N; [M+H]+; [(2S)-1-prop-2-ynylpyrrolidin-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.278; LPAIJTCPOYPLDO-UHFFFAOYSA-N; [M+H]+; 1-prop-2-ynylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.275; JCLLVTBCUGMKAT-UHFFFAOYSA-N; [M+H]+; 3-piperidin-2-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.258; UZHJWWNKUFBJHO-UHFFFAOYSA-N; [M+H]+; 2-(1-ethylpyrrol-2-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.257; OITIWHCOLGQTAF-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-3,3-dimethylcyclobutane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; RDTAATZMSHBUDM-UHFFFAOYSA-N; [M+H]+; 4-ethylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.248; GTEKSPGKRFEHRA-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylpiperidine-4-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.245; PXLWBYQKAOCCHM-UHFFFAOYSA-N; [M+H]+; 2-cyclopropyl-2,6-diazaspiro[3.3]heptane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.212; PIXBBFRQUKVNLN-UHFFFAOYSA-N; [M+H]+; 1-prop-2-ynyl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.209; CBRUYTAKOYULDK-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cyclohexylacetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.209; ZFXSRXFFVQUSJG-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; MTLXTAIUWACVSW-UHFFFAOYSA-N; [M+H]+; 1-(1-methylpyrrol-2-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.192; GIZMBLLDGLCEQX-UHFFFAOYSA-N; [M+H]+; 2-pyrrolidin-1-ylbutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.191; ACOLJMMCKXMANR-UHFFFAOYSA-N; [M+H]+; 2-(2-methylpiperidin-1-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.185; NOXAORINZJERRC-UHFFFAOYSA-N; [M+H]+; 1-methyl-4-prop-2-ynylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.178; QDKVKIHUOVMMCG-UHFFFAOYSA-N; [M+H]+; (1,2,5-trimethylpyrrol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.169; ZWKWOOLQWOHHSL-UHFFFAOYSA-N; [M+H]+; 1-but-3-ynylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.155; OHKGIEVCPHMZKY-UHFFFAOYSA-N; [M+H]+; 2-(azepan-1-yl)acetonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.152; GUGMWCUXIGSRJX-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-pyrrolidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.151; OLUSMJNIPLCWBR-UHFFFAOYSA-N; [M+H]+; N-prop-2-ynylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.144; OEVYDWMZOGZKIJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-(propan-2-ylamino)but-2-enenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.141; PUKVGBPMTQRQGP-UHFFFAOYSA-N; [M+H]+; 2-methyl-1-(1H-pyrrol-2-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.134; PAQTZJCQRHONNN-UHFFFAOYSA-N; [M+H]+; 1-(1-ethylpyrrol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; YHGZCPAPXDXHCY-UHFFFAOYSA-N; [M+H]+; 3-(cyclopentylamino)propanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.123; QXPUWXJUGPMKRK-UHFFFAOYSA-N; [M+H]+; bicyclo[2.2.1]heptane-2-carboximidamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.122; SSXMIBAFANQRTR-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; FKYWLZUPBICXFW-UHFFFAOYSA-N; [M+H]+; 4,9-diazatricyclo[5.3.0.02,6]decane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.049; AQVCJKMGVKNXCB-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-(1-methylpyrrol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -88.373; OHKGIEVCPHMZKY; [M+H]+; 1-Azepanylacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -95.271; OSDDDHPYSNZBPF; [M+H]+; 1-Pyrrolidinebutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.086; YZICFVIUVMCCOC; [M+H]+; Piperidinopropionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.082; NOXAORINZJERRC; [M+H]+; 1-Methyl-4-prop-2-ynyl-piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.138; ZFXSRXFFVQUSJG; [M+H]+; 1-(aminomethyl)cyclohexane-1-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -178.151; YHGZCPAPXDXHCY; [M+H]+; 3-(Cyclopentylamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.456; PXLWBYQKAOCCHM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -216.291; DSMAHJDZYJDGTD; [M+H]+; (1-cyanocyclohexyl)-methylazanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -231.625; WHLZPGRDRYCVRQ; [M+H]+; 1-butyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.657; IQQRAVYLUAZUGX; [M+H]+; [bmim]
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -258.011; AQVCJKMGVKNXCB; [M+H]+; 2-Dimethylaminomethyl-1-methylpyrrole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.771; AIUVAZQMVWSJEN; [M+H]+; 3,5-dimethyl-1-propan-2-ylpyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -272.916; RLEMOPKSUBPPLL; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -278.603; UPYVYJSWGZMBOU; [M+H]+; 1-pentylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.345; FPLOWPOUHNRUMN; [M+H]+; 2-pentan-3-yl-1H-imidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.318; OHKGIEVCPHMZKY; [M+H]+; 1-Azepanylacetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -72.284; OSDDDHPYSNZBPF; [M+H]+; 1-Pyrrolidinebutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -99.040; NOXAORINZJERRC; [M+H]+; 1-Methyl-4-(prop-2-yn-1-yl)piperazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -101.295; OHKGIEVCPHMZKY; [M+H]+; Hexahydro-1H-azepine-1-acetonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -102.707; GUGMWCUXIGSRJX; [M+H]+; 3,3-Dideuterio-2-methyl-2-pyrrolidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.033; PXLWBYQKAOCCHM; [M+H]+; 2-Cyclopropyl-2,6-diazaspiro[3.3]heptane
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -121.226; YZICFVIUVMCCOC; [M+H]+; Hydron;3-piperidin-1-ylpropanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -122.890; RINRSJBJOGCGBE; [M+H]+; 2,2,5,6-Tetramethyl-2,3-dihydropyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.228; YHGZCPAPXDXHCY; [M+H]+; 3-(Cyclopentylamino)propionitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -144.533; LPAIJTCPOYPLDO; [M+H]+; (3S)-1-prop-2-ynylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.054; WHLZPGRDRYCVRQ; [M+H]+; 1-Butyl-2-methylimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.607; OSDDDHPYSNZBPF; [M+H]+; 1-Pyrrolidinebutanenitrile
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C8H15N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 17.812
MS$FOCUSED_ION: PRECURSOR_M/Z 139.122962
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-2900000000-f0514c0b1437a3b6b6f8
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.9647461 27.3491 56.965380 1.7906 15.60 0.1819 98 ?
  70.0650505 32.4060 70.065670 1.3131 9.01 0.8432 107 f{C4H8N1}/-1.07ppm,p-C4H7N1
  96.0807676 51.0643 96.081120 1.4259 17.20 0.8626 109 f{C6H10N1}/-0.08ppm,p-C2H5N1
  97.0760650 148.7001 97.076410 0.7005 48.15 0.9211 109 f{C5H9N2}/0.42ppm,p-C3H6
  98.0964529 106.6578 98.096790 0.8461 29.56 0.9327 109 f{C6H12N1}/0.28ppm,p-C2H3N1
  111.0917044 120.8583 111.091920 0.9092 31.74 0.9290 109 f{C6H11N2}/0.27ppm,p-C2H4
  122.0964178 35.5816 122.096500 1.5971 11.79 0.8556 108 f{C8H12N1}/-0.07ppm,p-H3N1
  124.0995050 21.3000 124.099560 1.8775 6.19 0.8504 80 f{C7H12N2}/0.04ppm,p-C1H3
  139.0501751 20.8895 139.050080 1.9274 9.57 0.2123 106 ?
  139.0865851 79.0474 139.086490 0.7909 35.85 -0.0741 108 ?
  139.0978751 100.8697 139.097780 1.8908 46.44 0.0349 100 ?
  139.1229251 999.0000 139.122830 0.3881 0.00 1.0000 109 f{C8H15N2}/-0.36ppm,p
PK$NUM_PEAK: 12
PK$PEAK: m/z int. rel.int.
  56.964746 27.35 27
  70.065050 32.41 32
  96.080768 51.06 51
  97.076065 148.70 148
  98.096453 106.66 106
  111.091704 120.86 120
  122.096418 35.58 35
  124.099505 21.30 21
  139.050175 20.89 20
  139.086585 79.05 79
  139.097875 100.87 100
  139.122925 999.00 999
//
